Dose-dependent effects of atorvastatin on myocardial infarction

BACKGROUND: Dyslipidemia is a key factor determining the development of both myocardial infarction (MI) and its subsequent complications. Dyslipidemia is associated with endothelial dysfunction, activation of inflammation, thrombogenesis, and formation of insulin resistance. Statin therapy is though...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbarash, Olga, Gruzdeva, Olga, Uchasova, Evgenya, Belik, Ekaterina, Dyleva, Yulia, Karetnikova, Victoria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492625/
https://www.ncbi.nlm.nih.gov/pubmed/26170622
http://dx.doi.org/10.2147/DDDT.S86344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492625/
https://www.ncbi.nlm.nih.gov/pubmed/26170622
http://dx.doi.org/10.2147/DDDT.S86344

Ejemplares similares